Antigenic mimicry WORLD OF MICROBIOLOGY AND IMMUNOLOGY
30
•
from a single cell that produces a single antibody, then divides
many times. The cells that divided do not contain antibodies
and could, therefore, be crossed with lymphocytes to produce
specific antibodies. These hybrid cells are called hybridoma,
and they produce monoclonal antibodies.
One molecular biologist who needed pure antibodies for
a study of myeloma mutationswas the Argentinean César
Milstein(1927– ). After receiving a doctorate in biochemistry,
specializing in enzymes, from the University of Buenos Aires
in 1957, he continued this study at the University of
Cambridge in England. There he worked under the biochemist
Frederick Sanger and earned another doctorate in 1961.
Milstein had returned to Argentina, but political disturbances
forced him to flee the country. He came back to Cambridge,
where Sanger suggested that he work with antibodies.
In 1974, Milstein was working with Georges Köhler
(1946–1995), a German postdoctoral student who had just
received his doctorate from the University of Freiburg for
work performed at the Institute for Immunologyin Basel,
Switzerland. To produce the needed antibodies, Milstein and
Köhler first injected a mouse with a known antigen. After
extracting the resulting lymphocytes from the mouse’s blood,
they fused one of them with a myeloma cell. The resulting
hybrid produced the lymphocyte’s specific antibody and
reproduced endlessly. As Milstein soon realized, their tech-
nique for producing monoclonal antibodies could be used in
many capacities. Milstein and Köhler shared part of the 1984
Nobel prize in physiology or medicine for their invention.
Today pure antibodies are made using the Milstein-
Köhler technique and also through genetic engineering, which
adds the genefor the desired antibody to bacteria that can pro-
duce it in large amounts. Monoclonal antibodies are instru-
mental in the performance of sensitive medical diagnostic
tests such as: determining pregnancy with chorionic
gonadotropin; determining the amino acid content of sub-
stances; classifying antigens; purifying hormones; and modi-
fying infectious or toxic substances in the body. They are also
important in cancer treatment because they can be tagged with
radioisotopes to make images of tumors.
See alsoAntibody-antigen, biochemical and molecular reac-
tions; Antibody and antigen; Immunity, cell mediated;
Immunogenetics; Immunologic therapies; Immunological
analysis techniques; In vitroand in vivoresearch
ANTIGEN• seeANTIBODY AND ANTIGEN
AAntigenic mimicryNTIGENIC MIMICRY
Antigenic mimicry is the sharing of antigenic sites between
microorganismsand mammalian tissue. An immune response
can be directed both at the microorganism and at the host site
that shares the antigenic determinant. This autoimmune
response due to antigenic mimicry is known to be a crucial
factor in the development of certain ailments in humans.
The immune system recognizes three-dimensional
structure of protein. A protein, which is made up of a sequence
of amino acids strung together, will fold up in various ways,
depending on whether a section is more hydrophilic (“water
loving”) or hydrophobic(“water hating”), and depending on
the function of various regions of the protein.
Proteins that adopt a similar three-dimensional configu-
ration can stimulate a common response from the immune sys-
tem. Typically, proteins that have a similar amino acid
sequence will adopt the similar folded structures. For exam-
ple, the bacteriaChlamydia pneumoniae, Chlamydia psittaci,
and Chlamydia trachomatispossess a protein that is part of the
bacterial outer membrane. This protein is similar in amino
acid sequence to a portion of a protein, called alpha-myosin
heavy chain, which is found specifically in the heart muscle of
humans and animals such as mice. In mice, an immune reac-
tion to Chlamydia triggers a condition known as inflammatory
heart disease. A continued host autoimmune response damages
the heart, leading to cardiac malfunction. Indeed, it has been
shown that a significant number of patients with heart disease
have antibodies to Chlamydia in their blood, indicative of a
past infection with the bacteria.
Rheumatoid arthritis is another example of a malady
that is the consequence of an autoimmune reaction.
Mice used to develop the monoclonal cells that secret a specific
antibody.
womi_A 5/6/03 1:07 PM Page 30